CTOT 43_Eliminate_Kappus - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
CLINICAL TRIALS IN ORGAN TRANSPLANTATION-CHILDREN/ADULTS (CTOT-43)
EXPANDING LIVER TRANSPLANT IMMUNOSUPPRESSION MINIMIZATION VIA EVEROLIMUS
ELIMINATE
Principal Investigator
Matthew R. Kappus, MD
Hepatologist
Protocol Number
IRB:
PRO00115739
NCT:
NCT06280950
Phase
Phase II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment